Companies › Centene Corporation · Global Markets & Policy
Centene Corporation
- NYSE: CNC
U.S.-listed company (NYSE: CNC) that the SEC classifies under industry code 6324, "Hospital & Medical Service Plans".
Next earnings report: Oct 27, 2026. Centene Corporation quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $6.9M, purchases $0. All Centene Corporation insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Christopher Koster Secretary & General Counsel | Open-market sale | 56,500 | $66.90 | $3.8M | Form 4 ↗ |
| Aug 18, 2026 | Christopher Koster Secretary & General Counsel | Open-market sale | 47,603 | $65.36 | $3.1M | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $144.5B | $154.0B | $163.1B | $194.8B |
| Operating income | $1.3B | $2.9B | $3.2B | −$7.6B |
| Net income | $1.2B | $2.7B | $3.3B | −$6.7B |
| Diluted EPS | $2.07 | $4.95 | $6.31 | $-13.53 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-08 · 8-K — Other events
- 2026-09-16 · 8-K — Regulation FD disclosure
- 2026-08-17 · 8-K — Director or officer change; Regulation FD disclosure
- 2026-07-29 · 8-K — Other events
- 2026-07-28 · 8-K — Results of operations; Director or officer change; Regulation FD disclosure
- 2026-07-28 · 10-Q
- 2026-06-22 · 8-K — Director or officer change; Regulation FD disclosure
- 2026-05-15 · 8-K — Director or officer change; Shareholder vote results
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.